The store will not work correctly when cookies are disabled.
5-nitrobenzo[c][1,2,5]thiadiazole
ID: ALA206713
Cas Number: 16252-88-3
PubChem CID: 297897
Product Number: N697247, Order Now?
Max Phase: Preclinical
Molecular Formula: C6H3N3O2S
Molecular Weight: 181.18
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: 5-Nitrobenzo[C][1,2,5]Thiadiazole | 5-nitro-2,1,3-benzothiadiazole|16252-88-3|5-nitrobenzo[c][1,2,5]thiadiazole|5-nitrobenzo-2,1,3-thiadiazole|5-(Hydroxy(oxido)amino)-2,1,3-benzothiadiazole|K2T9C5FVT8|2,1,3-Benzothiadiazole, 5-nitro-|NSC169218|UNII-K2T9C5FVT8|NSC 169218|CHEMBL206713|NSC-169218|Maybridge1_005863|Oprea1_705286|SCHEMBL922633|HMS558C11|DTXSID60167385|BXZPSERJJMAPSV-UHFFFAOYSA-N|BDBM50182129|MFCD00114840|RDP 00064|AKOS003197175|AM806177|AS-61005|CS-0316448|EU-0066875|SR-01000389716|SShow More⌵
Canonical SMILES: O=[N+]([O-])c1ccc2nsnc2c1
Standard InChI: InChI=1S/C6H3N3O2S/c10-9(11)4-1-2-5-6(3-4)8-12-7-5/h1-3H
Standard InChI Key: BXZPSERJJMAPSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
12 13 0 0 0 0 0 0 0 0999 V2000
14.3077 1.7116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3066 0.8847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0210 0.4721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0192 2.1242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5162 1.9727 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7298 1.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7345 0.8846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5248 0.6345 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0057 1.3094 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.5929 2.1235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8789 1.7110 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5927 2.9481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 7 1 0
1 2 1 0
6 4 1 0
5 6 2 0
7 8 2 0
8 9 1 0
9 5 1 0
4 1 2 0
6 7 1 0
10 11 2 0
10 12 1 0
1 10 1 0
M CHG 2 10 1 12 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 181.18 | Molecular Weight (Monoisotopic): 180.9946 | AlogP: 1.60 | #Rotatable Bonds: 1 |
Polar Surface Area: 68.92 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.06 | CX LogD: 2.06 |
Aromatic Rings: 2 | Heavy Atoms: 12 | QED Weighted: 0.49 | Np Likeness Score: -2.47 |
References
1. Andricopulo AD, Akoachere MB, Krogh R, Nickel C, McLeish MJ, Kenyon GL, Arscott LD, Williams CH, Davioud-Charvet E, Becker K.. (2006) Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents., 16 (8): [PMID:16458512] [10.1016/j.bmcl.2006.01.027] |